Last reviewed · How we verify

NCT03856463: CAREPlan

Coaches Activating Reaching and Engaging Patients

Completed NA Last updated 21 March 2024
What this trial tests

NA trial testing Lay Navigator Intervention in Cancer in 400 participants. Completed in 25 September 2023.

Timeline
3 April 2019
Primary endpoint
3 April 2023
25 September 2023

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposehealth services research
Enrollment400
Start date3 April 2019
Primary completion3 April 2023
Estimated completion25 September 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, any sex, with Cancer or End-of-Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the Team Based Advance Care Planning CAREPLAN program is to understand if a trained lay navigator who engages with patients with advanced stages of cancer can help patients in advance care planning, improve patient activation, satisfaction, quality of life, and the quality of end of life cancer care while also ensuring goal concordant cancer care at the end of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Coaches Activating, Reaching, and Engaging Patients to Engage in Advance Care Planning: A Randomized Clinical Trial.
    Rodriguez GM, Parikh DA, Kapphahn K, Gupta DM, et al · · 2024 · cited 3× · PMID 38780960 · DOI 10.1001/jamaoncol.2024.1242

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03856463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing